Literature DB >> 21611853

Protective role of taurine against morphine-induced neurotoxicity in C6 cells via inhibition of oxidative stress.

Jiaqing Zhou1, Yan Li, Guangyan Yan, Qian Bu, Lei Lv, Yanzhu Yang, Jinxuan Zhao, Xue Shao, Yi Deng, Ruimin Zhu, Yinglan Zhao, Xiaobo Cen.   

Abstract

This study was carried out to investigate the protective role of taurine (2-aminoethanesulphonicacid) against morphine-induced neurotoxicity in C6 cells. It was found that taurine significantly increased the viability of C6 cells treated by morphine, showing the neuroprotective role against morphine-induced neurotoxicity. However, such neuroprotective effect of taurine could not be blocked by bicuculline, an antagonist of gamma-amino butyrate (GABA) receptor. To determine the oxidative damage induced by morphine, the superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx) were measured in C6 cells. The decreased activities of SOD, CAT, and GPx in C6 cells were observed after morphine treatment for 48 h. However, taurine administration effectively ameliorated morphine-induced oxidative insult. To estimate anti-apoptosis effect of taurine, flow cytometry analysis as well as detection for caspase-3 and Bcl-2 expressions was performed after morphine exposure for 48 h. It was found that Bcl-2 expression was down regulated by morphine, whereas taurine could reverse morphine-induced decrease in Bcl-2 expression. Taurine showed no effect on caspase-3 expression. Collectively, the results show that taurine possesses the capability to ameliorate morphine-induced oxidative insult and apoptosis in C6 cells, probably due to its antioxidant activity rather than activation of GABA receptors.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21611853     DOI: 10.1007/s12640-011-9247-x

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  51 in total

1.  Mode of action of taurine as a neuroprotector.

Authors:  Heng Wu; Ying Jin; Jianning Wei; Hong Jin; Di Sha; Jang-Yen Wu
Journal:  Brain Res       Date:  2005-03-21       Impact factor: 3.252

2.  Taurine activates GABA(A) but not GABA(B) receptors in rat hippocampal CA1 area.

Authors:  N del Olmo; J Bustamante; R M del Río; J M Solís
Journal:  Brain Res       Date:  2000-05-12       Impact factor: 3.252

3.  Acute decreases in cerebrospinal fluid glutathione levels after intracerebroventricular morphine for cancer pain.

Authors:  L C Goudas; A Langlade; A Serrie; W Matson; P Milbury; C Thurel; P Sandouk; D B Carr
Journal:  Anesth Analg       Date:  1999-11       Impact factor: 5.108

4.  Etorphine inhibits cell growth and induces apoptosis in SK-N-SH cells: involvement of pertussis toxin-sensitive G proteins.

Authors:  D L Yin; X H Ren; Z L Zheng; L Pu; L Z Jiang; L Ma; G Pei
Journal:  Neurosci Res       Date:  1997-10       Impact factor: 3.304

5.  Opioid neurotoxicity: comparison of morphine and tramadol in an experimental rat model.

Authors:  Sebnem Atici; Leyla Cinel; Ismail Cinel; Nurcan Doruk; Mustafa Aktekin; Almila Akca; Handan Camdeviren; Ugur Oral
Journal:  Int J Neurosci       Date:  2004-08       Impact factor: 2.292

6.  Metabolic changes in rat prefrontal cortex and hippocampus induced by chronic morphine treatment studied ex vivo by high resolution 1H NMR spectroscopy.

Authors:  Hongchang Gao; Yun Xiang; Ninglei Sun; Hang Zhu; Yaqiang Wang; Maili Liu; Yuanye Ma; Hao Lei
Journal:  Neurochem Int       Date:  2006-10-30       Impact factor: 3.921

7.  Nonclassical secretion of human catalase on the surface of CHO cells is more efficient than classical secretion.

Authors:  Zuyong He; Xiuzhu Sun; Gui Mei; Shengli Yu; Ning Li
Journal:  Cell Biol Int       Date:  2007-12-23       Impact factor: 3.612

8.  Taurine prevents the neurotoxicity of beta-amyloid and glutamate receptor agonists: activation of GABA receptors and possible implications for Alzheimer's disease and other neurological disorders.

Authors:  Paulo Roberto Louzada; Andréa C Paula Lima; Dayde L Mendonca-Silva; François Noël; Fernando G De Mello; Sérgio T Ferreira
Journal:  FASEB J       Date:  2004-03       Impact factor: 5.191

9.  Therapeutic manipulation of peroxynitrite attenuates the development of opiate-induced antinociceptive tolerance in mice.

Authors:  Carolina Muscoli; Salvatore Cuzzocrea; Michael M Ndengele; Vincenzo Mollace; Frank Porreca; Francesca Fabrizi; Emanuela Esposito; Emanuela Masini; George M Matuschak; Daniela Salvemini
Journal:  J Clin Invest       Date:  2007-11       Impact factor: 14.808

10.  Nanosized zinc oxide particles induce neural stem cell apoptosis.

Authors:  Xiaoyong Deng; Qixia Luan; Wenting Chen; Yanli Wang; Minghong Wu; Haijiao Zhang; Zheng Jiao
Journal:  Nanotechnology       Date:  2009-02-24       Impact factor: 3.874

View more
  23 in total

1.  Effect of oleuropein on morphine-induced hippocampus neurotoxicity and memory impairments in rats.

Authors:  Farhad Shibani; Ali Sahamsizadeh; Iman Fatemi; Mohammad Allahtavakoli; Jalal Hasanshahi; Mohammadreza Rahmani; Mahdieh Azin; Mahsa Hassanipour; Nazanin Mozafari; Ayat Kaeidi
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-06-24       Impact factor: 3.000

2.  Effect of taurine on the proliferation and apoptosis of human hepatocellular carcinoma HepG2 cells.

Authors:  Shuo Tu; Xiali Zhang; Daya Luo; Zhuoqi Liu; Xiaohong Yang; Huifang Wan; Lehan Yu; Hua Li; Fusheng Wan
Journal:  Exp Ther Med       Date:  2015-05-07       Impact factor: 2.447

3.  Pretreatment of liver grafts in vivo by γ-aminobutyric acid receptor regulation reduces cold ischemia/warm reperfusion injury in rat.

Authors:  Tomohide Hori; Lindsay B Gardner; Toshiyuki Hata; Feng Chen; Ann-Marie T Baine; Shinji Uemoto; Justin H Nguyen
Journal:  Ann Transplant       Date:  2013-06-17       Impact factor: 1.530

4.  Liver graft pretreated in vivo or ex vivo by γ-aminobutyric acid receptor regulation.

Authors:  Tomohide Hori; Lindsay B Gardner; Florence Chen; Ann-Marie T Baine; Toshiyuki Hata; Shinji Uemoto; Justin H Nguyen
Journal:  J Surg Res       Date:  2012-09-15       Impact factor: 2.192

5.  In vivo and in vitro attenuation of naloxone-precipitated experimental opioid withdrawal syndrome by insulin and selective KATP channel modulator.

Authors:  Prabhat Singh; Bhupesh Sharma; Surbhi Gupta; B M Sharma
Journal:  Psychopharmacology (Berl)       Date:  2014-07-26       Impact factor: 4.530

6.  NMR-Based Metabolic Profiling Reveals Neurochemical Alterations in the Brain of Rats Treated with Sorafenib.

Authors:  Changman Du; Xue Shao; Ruiming Zhu; Yan Li; Qian Zhao; Dengqi Fu; Hui Gu; Jueying Kong; Li Luo; Hailei Long; Pengchi Deng; Huijuan Wang; Chunyan Hu; Yinglan Zhao; Xiaobo Cen
Journal:  Neurotox Res       Date:  2015-08-02       Impact factor: 3.911

7.  Effect of specific activation of γ-aminobutyric acid receptor in vivo on oxidative stress-induced damage after extended hepatectomy.

Authors:  Lindsay B Gardner; Tomohide Hori; Feng Chen; Ann-Marie T Baine; Toshiyuki Hata; Shinji Uemoto; Justin H Nguyen
Journal:  Hepatol Res       Date:  2012-05-14       Impact factor: 4.288

8.  Taurine ameliorates thioacetamide induced liver fibrosis in rats via modulation of toll like receptor 4/nuclear factor kappa B signaling pathway.

Authors:  Nancy S Younis; Amal M H Ghanim; Mohammad A Elmorsy; Heba A Metwaly
Journal:  Sci Rep       Date:  2021-06-10       Impact factor: 4.379

9.  Protective role of taurine against oxidative stress (Review).

Authors:  Stella Baliou; Maria Adamaki; Petros Ioannou; Aglaia Pappa; Mihalis I Panayiotidis; Demetrios A Spandidos; Ioannis Christodoulou; Anthony M Kyriakopoulos; Vassilis Zoumpourlis
Journal:  Mol Med Rep       Date:  2021-06-29       Impact factor: 2.952

10.  A Systematic, Integrated Study on the Neuroprotective Effects of Hydroxysafflor Yellow A Revealed by (1)H NMR-Based Metabonomics and the NF-κB Pathway.

Authors:  Yuanyan Liu; Zeqin Lian; Haibo Zhu; Yinghong Wang; Shishan Yu; Tingting Chen; Jing Qu; Jianbei Li; Shuanggang Ma; Xianhong Chen
Journal:  Evid Based Complement Alternat Med       Date:  2013-04-22       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.